How much does semaglutide cost without insurance?

The Real Numbers for April 2026

"How much does semaglutide cost without insurance" has several answers depending on which version you're asking about and through which channel. Let's lay out all the paths honestly.

Brand Wegovy (FDA-approved for obesity)

• Manufacturer list price: ~$1,350/month for the 2.4 mg maintenance dose
• Cash at pharmacy with Novo Nordisk savings card (uninsured): ~$500–$650/month
• LillyDirect-style direct purchase: Novo Nordisk launched a similar direct-to-patient option; Wegovy cash prices through that channel have settled in the $499–$699/month range depending on dose

Brand Ozempic (FDA-approved for type 2 diabetes)

• List price: ~$970/month
• Cash price at pharmacy: often $900–$1,100 depending on pharmacy markup
• Manufacturer savings programs apply primarily to insured patients; uninsured savings are limited

Rybelsus (oral semaglutide tablet)

• List price: ~$1,000/month
• Cash price: often $900–$1,050

Compounded Semaglutide Through Telehealth

The compounded semaglutide landscape has shifted substantially over the past two years following FDA compounding enforcement actions. As of April 2026:

• Compounded semaglutide remains available through 503A compounding pharmacies for individual patients when clinically justified
• Typical telehealth pricing: $150–$400/month, including provider visit
• Prices at the low end tend to reflect lower initial doses (0.25 mg weekly titration phase); therapeutic maintenance doses (2.4 mg weekly) trend toward the high end
• Quality and regulatory posture varies substantially by clinic and pharmacy — cheaper is not always better

Pharmacy Comparison for Brand Wegovy

Cash pricing for brand Wegovy across major pharmacies tends to fall in a narrow range because of manufacturer price coordination, but you can see variation:

• CVS: ~$1,349/month list
• Walgreens: ~$1,349/month list
• Walmart: ~$1,349/month list
• Costco: often $50–$100 below list price
• GoodRx cash card: occasional $1,100–$1,200 deals but rarely meaningful for GLP-1s

HSA and FSA Use

HSA and FSA funds can typically be used for brand semaglutide when prescribed for a qualifying medical condition. Compounded semaglutide can sometimes be reimbursed, but plan administrators are inconsistent — get an itemized receipt with diagnosis coding and verify coverage before assuming.

Why Compounded Is So Much Cheaper

Compounded semaglutide bypasses brand-drug overhead: no FDA-level clinical trial amortization, no brand marketing, no distribution through traditional pharmacy supply chains. The tradeoff is regulatory status: compounded preparations are patient-specific, not FDA-approved, and quality depends on the compounding pharmacy. Price delta reflects regulatory envelope more than manufacturing cost difference.

Insurance Coverage Reality

Coverage has expanded significantly from where it was in 2023:

• Most commercial plans now cover Wegovy for obesity if BMI criteria are met
• Medicare coverage remains inconsistent, expanding gradually
• Medicaid coverage varies state-by-state, still partial
• Employer-sponsored plans increasingly cover GLP-1s, often with prior authorization

If you're paying cash because of assumed lack of coverage, re-verify — the 2026 coverage landscape is better than it was two years ago.

Real Monthly Cost by Path

• Cheapest path — compounded telehealth during titration: $150–$250/month
• Compounded telehealth at maintenance dose: $250–$400/month
• Brand with manufacturer cash program: $500–$700/month
• Brand full cash, no programs: $900–$1,400/month
• Brand with insurance coverage: $25–$100/month copay (when covered)

See the main semaglutide guide or browse providers. Related: semaglutide vs tirzepatide cost, cheapest compounded sources.